Adi Livneh

Director/Miembro de la Junta en New N.I. Medical (2011) Ltd. .

64 años

Consumer Non-Durables

Health Technology

Perfil

Adi Livneh is currently a Director at New N.I.
Medical (2011) Ltd.
In the past, Livneh worked as the Chief Executive Officer at Tefron Ltd.
from 2008 to 2009.

Cargos activos de Adi Livneh

Empresas	Cargo	Inicio
New N.I. Medical (2011) Ltd. New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev.	Director/Miembro de la Junta	-

Todos los cargos activos de Adi Livneh

Antiguos cargos conocidos de Adi Livneh.

Empresas	Cargo	Fin
TEFRON LTD.	Presidente	17/11/2009

Ver el detalle de la experiencia de Adi Livneh.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Adi Livneh.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
TEFRON LTD.	Consumer Non-Durables

Empresas privadas	1
New N.I. Medical (2011) Ltd. New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev.	Health Technology